Turitz Andrew 4
4 · Teladoc Health, Inc. · Filed Jun 4, 2024
Insider Transaction Report
Form 4
Turitz Andrew
SVP - Business Development
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-05-31−1,348→ 4,044 total→ Common Stock (1,348 underlying) - Exercise/Conversion
Common Stock
2024-05-31+1,348→ 36,186 total - Exercise/Conversion
Common Stock
2024-05-31+1,056→ 34,838 total - Sale
Common Stock
2024-06-03$11.16/sh−1,627$18,152→ 37,659 total - Exercise/Conversion
Restricted Stock Units
2024-05-31−3,100→ 21,702 total→ Common Stock (3,100 underlying) - Exercise/Conversion
Common Stock
2024-05-31+3,100→ 39,286 total - Exercise/Conversion
Performance Stock Units
2024-05-31−1,056→ 7,397 total→ Common Stock (1,056 underlying)
Footnotes (6)
- [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- [F4]On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F5]On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F6]On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.